NRXP NRx Pharmaceuticals, Inc.
$2.85
NRx Pharmaceuticals, Inc. (NRXP) SEC Filings
Everything NRXP has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.
| Date | Form | Filing |
|---|---|---|
| 8-K Other Event · Other Reg Fd | View filing | |
| 8-K Investor Presentation · Reg Fd | View filing | |
| 8-K Capital Raise · Earnings Release · Executive Change · Material Agreement | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K | View filing | |
| 4 | View filing | |
| 10-Q | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 4 | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K/A | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K/A | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-K/A | View filing | |
| 10-Q | View filing | |
| 10-K/A | View filing | |
| 10-K | View filing | |
| 10-Q | View filing | |
| 10-Q | View filing | |
| 10-Q/A | View filing | |
| 10-Q | View filing | |
| 10-K/A | View filing | |
| 10-K | View filing | |
| 10-Q | View filing |
Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.